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MaRecent attention has focused on fructose as having a unique role in the pathogenesis of cardiometabolic diseases.
However, because we rarely consume fructose in isolation, the major source of fructose in the diet comes from fructose-
containing sugars, sucrose and high fructose corn syrup, in sugar-sweetened beverages and foods. Intake of sugar-
sweetened beverages has been consistently linked to increased risk of obesity, type 2 diabetes, and cardiovascular
disease in various populations. Putative underlying mechanisms include incomplete compensation for liquid calories,
adverse glycemic effects, and increased hepatic metabolism of fructose leading to de novo lipogenesis, production of uric
acid, and accumulation of visceral and ectopic fat. In this review we summarize the epidemiological and clinical trial
evidence evaluating added sugars, especially sugar-sweetened beverages, and the risk of obesity, diabetes, and car-
diovascular disease and address potential biological mechanisms with an emphasis on fructose physiology. We also
discuss strategies to reduce intake of fructose-containing beverages. (J Am Coll Cardiol 2015;66:1615–24) © 2015 by the
American College of Cardiology Foundation.T he adverse health effects of sugar have longbeen amatter of much public and scientiﬁc in-terest. For decades, it has been thought that a
high intake of sugar is associated with the develop-
ment of obesity, type 2 diabetes, and cardiovascular
disease (CVD). Given the distinct metabolic fates that
differentiate fructose from glucose, recent attention
has focused on fructose as having a unique role in the
etiology of these conditions. Fructose is found in su-
crose or common table sugar, which is a disaccharide
composed of 1 glucose molecule and 1 fructose mole-
cule linked via an a1-4 glycoside bond, and is obtained
from either sugar cane or beets. Fructose and glucose
are also both found as naturally occurring monosac-
charides that exist in fruit, honey, and some vegeta-
bles. Sweeteners such as high fructose corn syrup
(HFCS), which is produced from corn starch through
industrial processing, contain free fructose and free
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cessed foods including canned foods (e.g., soups and
fruits), cereals, baked goods, desserts, sweetened
dairy products, condiments, fruit-ﬂavored noncarbo-
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On the basis of national survey data from the United
States, mean intake of total fructose as a percentage of
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2004, with greater increases observed in adolescents
and young adults (1). It is important to note that this
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TABLE 1 Mean Inta
of Various Foods Am
and Nutrition Exami
Mean intake of added
1. Soda/energy/sports
2. Grain-based desser
3. Fruit drinks
4. Dairy desserts
5. Candy
6. Ready-to-eat cerea
7. Sugars/honey
8. Tea
9. Yeast breads
10. Syrups/toppings
*Rank for all persons onl
National Cancer Institute.
to 2006.
ABBR EV I A T I ON S
AND ACRONYMS
BMI = body mass index
CVD = cardiovascular disease
GL = glycemic load
HFCS = high fructose
corn syrup
RCT = randomized
controlled trial
SSB = sugar-sweetened
beverage
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1616fructose in fruit. With the exception of chil-
dren 1 to 3 years of age, the estimated intake of
naturally occurring fructose decreased from 11
to 16 g/day in 1978 to 7 to 9 g/day in 2004 for all
age groups, representing an overall decrease
of 3 to 7 g/day (1).
Because we rarely consume fructose in
isolation, the major source of fructose in the
diet comes from fructose-containing sugars
(sucrose and HFCS) largely in the form of
added sugar (i.e., those sugars that are added
to foods and beverages during processing andpreparation). As a result, glucose intake tends to co-
vary with fructose intake, and epidemiological studies
cannot completely differentiate between the effects of
fructose per se and those speciﬁcally attributable to
glucose.
Time-trend data over the past 3 to 4 decades have
shown a close parallel between the rise in added
sugar intake and the obesity and diabetes epidemics
in the United States (2). Largely driving these trends
has been the dramatic increase in the consumption of
sugar-sweetened beverages (SSBs), which are the
single greatest source of calories and added sugars in
the U.S. diet, accounting for nearly one-half of all
added sugar intake (3) (Table 1). One 360-ml can of
regular soda contains about 35 g of sugar (140 calo-
ries) or 7% of total calories (on the basis of 2,000 kcal/
day) (4). In the United States, SSBs are primarily
sweetened with HFCS, whereas in Europe sucrose is
the predominant sweetener.
Consumption of SSBs thus accounts for the ma-
jority of total fructose intake in the diet, either fromke of Added Sugars and Percentage Contribution
ong the U.S. Population by Age, National Health
nation Survey 2005–2006
All Persons
(n ¼ 8,272)
2 to 18 Years
(n ¼ 3,553)
19þ Years
(n ¼ 4,719)
sugars, tsp 21 23 20
Food Group by Rank*
drinks 35.7 31.8 37.1
ts 12.9 10.9 13.7
10.5 15.0 8.9
6.6 7.9 6.1
6.1 6.8 5.8
ls 3.8 6.4 2.9
3.5 1.4 4.2
3.5 2.1 4.0
2.1 1.9 2.2
1.9 2.8 1.5
y. Columns for other age groups are ordered by this ranking. Data from
Sources of calories from added sugars among the US population, 2005sucrose or HFCS, and in this regard, relations between
SSB and cardiometabolic diseases reﬂect potential
effects of fructose and glucose or unique metabolic
effects of fructose alone in epidemiologic studies
(Table 2).
Although consumption of SSBs and added sugar
appear to have decreased modestly in the past decade
(4), data from NHANES (National Health and Nutrition
Examination Survey) show that one-half of the U.S.
population consumes SSBs on a given day, with 1 in 4
obtaining at least 200 calories from these beverages
and 5% obtaining at least 567 calories—equivalent to 4
cans of soda (5). These values exceed American Heart
Association recommendations for no more than 100 to
150 kcal/day from all added sugar for most adults as
well as recommendations from the World Health Or-
ganization and the 2015 Dietary Guidelines Advisory
Committee to limit intake of added sugars to no more
than 10% of energy.
Over the past decade, a large body of evidence has
accumulated that shows a strong association between
SSBs and obesity and related chronic diseases (6–8).
For this reason and because they provide “empty”
calories and almost no nutritional value, SSBs have
been identiﬁed as a suitable target for public health
interventions. However, controversy remains over
whether the associations are causal, if glucose or
fructose moieties of sugars differentially affect car-
diometabolic risk, and what type of public action
should be taken on the basis of existing evidence. In
this review, we provide a brief overview of fructose
metabolism and summarize the epidemiological evi-
dence evaluating the relationship among fructose,
obesity, diabetes, and cardiovascular risk in adults,
focusing on fructose-containing beverages or SSBs,
because they are the most abundant and well-
characterized source of fructose in the diet. We also
discuss biological mechanisms underlying these as-
sociations with an emphasis on the role of fructose.
Finally, we discuss healthier alternatives to SSBs and
strategies to reduce SSB intake.
FRUCTOSE METABOLISM
Fructose metabolism differs from that of glucose in 2
major ways. First, there is nearly complete hepatic
extraction of fructose, and second, as shown in
Figure 1, there are different enzymatic reactions in the
initial steps of the metabolism of fructose and glucose.
Fructose is absorbed from the gut into the portal
vein and is metabolized in the liver, where it is con-
verted into fructose-1-phosphate by the enzyme
fructokinase. Fructose-1-phosphate is then split into
2 3-carbon molecules, namely glyceraldehyde and
TABLE 2 Key Points Regarding Fructose, HFCS, and SSBs
Fructose
 Fructose is found in: sucrose, a disaccharide composed of
1 glucose molecule and 1 fructose molecule; HFCS, containing
relatively equal amounts of glucose; and fruit, honey, and some
vegetables as a naturally occurring monosaccharide.
 The major source of fructose in the diet comes from fructose-
containing sugars (sucrose and HFCS) that are added to foods
and beverages and contain relatively equal amounts of glucose.
 Thus, intakes of glucose and fructose covary, and epidemio-
logical studies cannot completely differentiate between their
effects.
HFCS
 HFCS is produced from corn starch through industrial pro-
cessing. The most common forms contain 42% or 55% fructose
along with glucose and water.
 Use of HFCS has progressively replaced the use of sugar in the
United States due to its low cost.
 HFCS is the primary sweetener used in SSBs in the United States
and in many processed foods.
SSBs
 SSBs include soft drinks, fruit drinks, and energy drinks that are
sweetened by HFCS or sucrose, which are added to the bever-
ages by manufacturers, establishments, or individuals.
 SSBs are the greatest source of fructose-containing sugars in the
diet and thus account for the majority of total fructose intake.
 Relations between SSB and cardiometabolic diseases reﬂect the
potential effects of fructose and glucose or unique metabolic
effects of fructose alone in epidemiological studies.
HFCS ¼ high fructose corn syrup; SSB ¼ sugar-sweetened beverage.
FIGURE 1 Fructose Metabolism in Liver Cells
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Fructose metabolism (red arrows) differs from glucose (blue arrows) due to:
1) a nearly complete hepatic extraction; and 2) different enzyme and reactions
for its initial metabolic steps. Fructose taken up by the liver can be oxidized to
CO2 and then converted into lactate and glucose; glucose and lactate are
subsequently either released into the circulation for extrahepatic metabolism
or converted into hepatic glycogen or fat. The massive uptake and phos-
phorylation of fructose in the liver can lead to a large degradation of aden-
osine triphosphate to AMP and uric acid. Reprinted with permission from
Tappy L, Lê KA. Metabolic effects of fructose and the worldwide increase in
obesity. Physiol Rev 2010;90:23–46. AcetylCo-A ¼ acetyl coenzyme A; ADP ¼
adenosine diphosphate; AMP ¼ adenosine monophosphate; ATP ¼ adenosine
triphosphate; diP ¼ diphosphate; P ¼ phosphate.
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1617dihydroxyacetone phosphate, by aldolase. Glyceral-
dehyde is further converted into glyceraldehyde-
3-phosphate, which, along with dihydroxyacetone
phosphate, can then enter variousmetabolic pathways
to form “classical” energy substrates such as glucose,
glycogen, lactate, and fatty acids. Because these pro-
cesses are not dependent on insulin, fructose is
metabolized without requiring insulin secretion and
without increasing plasma glucose.
Of particular note, unlike glucose, fructose can
bypass the main rate limiting step of glycolysis at the
level of phosphofructokinase, allowing it to act as a
substrate for hepatic de novo lipogenesis and pro-
duction of lipids. Thus, intake of fructose in high
amounts can promote triglyceride synthesis from
unchecked pathways. The actual amount of fructose
needed to increase blood triglyceride levels is debated
(9). Signiﬁcant increases in post-prandial triglycerides
have been shown in response to consumption of 25%
of energy from fructose and HFCS, but not glucose
(10). Recent data has also shown that consuming
HFCS-sweetened beverages containing 10% to 25% of
energy produced signiﬁcant linear increases in post-
prandial triglycerides, suggesting a dose–response
relationship between fructose consumption and in-
creases in triglycerides (11). Because added sugar
intake in the United States constitutes about 14.9% of
energy, with 71% of the population consuming $10%
energy from added sugar (4), these effects of fructose
are relevant to usual consumption patterns.The massive uptake and phosphorylation of fruc-
tose in the liver can also deplete intracellular aden-
osine triphosphate, leading to an increase in uric acid
production, which has been shown to induce meta-
bolic complications. These differences in hepatic
metabolism can theoretically lead to a variety of
different short- and long-term cardiometabolic ef-
fects of fructose compared with glucose.
ADDED SUGARS AND SSBs IN
RELATION TO OBESITY, DIABETES,
AND CARDIOVASCULAR RISK
SSBs are a major source of added sugars (including
both fructose and glucose) in U.S. diets. Numer-
ous epidemiological studies have evaluated the rela-
tionship between consumption of SSBs and the
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1618development of obesity and related cardiometabolic
conditions in adults. Cross-sectional and ecological
studies are not able to establish temporality and infer
causality; thus, evidence from these designs are not
discussed in this review. Rather, we consider carefully
conducted and analyzed prospective cohort studies,
which are considered the strongest nonrandomized
study design, able to capture long-term diet and dis-
ease relationships. All of these studies adjusted their
analyses for potential confounding by various diet and
lifestyle factors; however, residual confounding by
unmeasured or imperfectly measured factors may still
exist. Higher SSB or sugar intake could be a marker
of a globally unhealthy diet. Therefore, incomplete
adjustment for various lifestyle factors could lead to
an overestimation of associations. Although random-
ized controlled trials (RCTs) with hard clinical out-
comes are regarded as the highest grade of evidence in
epidemiology, they are not the most appropriate or
feasible study design to evaluate long-term effects of
diet on disease. However, RCTs of intermediate out-
comes can provide important mechanistic insight.
Most of the studies that we consider deﬁned SSBs to
include carbonated and noncarbonated soft drinks
and sweetened fruit drinks that contain caloric
sweeteners; however, slight differences in deﬁnitions
are expected due to heterogeneity in assessment
methods. Such differences are unlikely to affect levels
of fructose consumption.
OBESITY: OBSERVATIONAL STUDIES
The majority of (3,6,7) but not all (12) systematic re-
views have reported positive associations between
SSB and weight gain or risk of overweight or obesity.
We recently conducted a comprehensive systematic
review and meta-analysis of cohort studies and RCTs
of SSBs and weight gain in children and adults (7). On
the basis of 7 cohort studies in adults, with 174,252
participants, a 1-serving/day increase in SSBs was
associated with an additional weight gain of 0.12 kg
over 1 year. Although this estimate seems modest,
adult weight gain in the general population is a
gradual process, occurring over decades and aver-
aging about 1 lb/year (0.45 kg/year). Thus, elimi-
nating SSBs from the diet could be an effective way to
prevent age-related weight gain.
The association between SSBs and obesity is
strengthened by our analysis of gene–SSB in-
teractions, which examined whether consumption of
SSBs can modify the genetic risk of obesity, using a
genetic predisposition score on the basis of 32 obesity
genes identiﬁed from genome-wide association
studies (13). On the basis of data from 3 large cohorts,we found that individuals who consumed $1 SSB
serving/day had genetic effects on body mass index
(BMI) and obesity risk that were approximately twice
as large as those who consumed <1 serving/month.
These data suggest that regular consumers of SSBs
may be more susceptible to genetic effects on obesity,
implying that a genetic predisposition to obesity can
be partly offset by healthier beverage choices.
OBESITY: RCTs
Compared with observational studies, evidence from
RCTs is limited, and the majority of trials evaluate
short-term effects of speciﬁc interventions on weight
change rather than long-term patterns. In our recent
meta-analysis of 5 trials including 292 adults, we found
that adding SSBs to the diet signiﬁcantly increased
body weight (7). Similarly, another meta-analysis of
7 RCTs found a signiﬁcant dose-dependent increase in
body weight when SSBs were added to participants’
diets (12). However, in their meta-analysis of another 8
trials aiming to reduce SSB consumption (for preven-
tion of weight gain), therewas no overall effect on BMI,
but a signiﬁcant beneﬁt was observed among in-
dividuals who were initially overweight (12). This
meta-analysis included 2 large and rigorously con-
ducted RCTs in children and adolescents (14,15), which
have overcome many of the limitations of previous
trials such as small sample sizes, short duration, lack of
blinding, and poor compliance. Although the trial by
Ebbeling et al. (14) found that reducing SSBs had a
signiﬁcant beneﬁt on BMI in the ﬁrst year of the trial
during active intervention, it did not ﬁnd a signiﬁcant
between-group difference after an additional 1 year of
follow-up without active intervention (14). This
ﬁnding actually supports rather than refutes a beneﬁt
of reducing SSB consumption on adolescent obesity,
suggesting that to achieve long-term beneﬁts, the
intervention needs to be sustained over time. These
studies provide strong evidence that decreasing con-
sumption of SSBs signiﬁcantly reduces weight gain
and obesity in this age group.
TYPE 2 DIABETES
A growing body of evidence indicates that SSB con-
sumption is associated with increased risk of diabetes
through effects on adiposity and independently
through other metabolic effects. Although experi-
mental evidence from RCTs is lacking due to high cost
and other feasibility considerations, ﬁndings from
prospective cohort studies have shown a relatively
strong and consistent association in well-powered
studies. We conducted a meta-analysis of 8 prospec-
tive cohort studies evaluating SSB intake and risk of
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1619diabetes (8). On the basis of 310,819 participants and
15,043 cases, individuals in the highest category of SSB
intake (usually 1 to 2 servings/day) had a 26% greater
risk of developing diabetes compared with those in the
lowest category (none or <1 serving/month). For this
analysis, we selected estimates that did not adjust for
potential intermediates in the etiologic chain, such as
total energy intake and BMI. A similar association was
found in a subcohort of 15,374 participants and 11,684
incident cases from the EPIC (European Prospective
Investigation into Cancer and Nutrition) study (16),
where a 1-serving/day increase in SSBs was associated
with a 22% increased risk of diabetes. A recent meta-
analysis of 17 cohort studies found that a 1-serving/
day increase in SSBs was associated with an 18%
increased risk of diabetes. Adjusting for BMI reduced
this estimate to 13%. Given the similar estimates from
studies in the United States where HFSC is the primary
sweetener and in Europe where sucrose is used, there
does not appear to be any appreciable difference
regarding the effect of sweetener type on risk of dia-
betes. However, food sources of fructose may make a
difference in metabolic effects. Some studies have
shown beneﬁcial effects of whole fruit consumption
on risk of diabetes, whereas higher consumption of
fruit juices was associated with increased risk (17).
These results indicate that the liquid versus solid
forms of calories from sugars may affect metabolic
diseases differently. Fructose in beverages is absorbed
more quickly than fructose in whole foods such as fruit
and vegetables, which are absorbed more slowly due
to their ﬁber content and slow digestion. The rapid
absorption of liquid fructose increases the rate of he-
patic extraction of fructose, de novo lipogenesis, and
production of lipids.
CARDIOVASCULAR RISK
There is increasing evidence that higher SSB con-
sumption increases cardiovascular risk by contrib-
uting to the development of hypertension,
dyslipidemia, inﬂammation, coronary heart disease,
and stroke. In over 88,000 women in the NHS
(Nurses’ Health Study) followed for 24 years, we
found that those who consumed $2 servings/day of
SSBs had a 35% greater risk of coronary heart disease
(CHD) (nonfatal myocardial infarction or fatal CHD)
compared with infrequent consumers (18). Additional
adjustment for potential mediating factors (including
BMI, total energy intake, and incident diabetes)
attenuated the association, but it remained statisti-
cally signiﬁcant, suggesting that the effect of SSBs
may not be entirely mediated by these factors. Similar
results were found in the HPFS (Health ProfessionalsStudy) among 42,883 men (19). In this study, intake of
SSBs was also signiﬁcantly associated with increased
plasma concentrations of inﬂammatory cytokines (19).
Recent evidence has also emerged linking intake of
SSBs to increased risk of stroke. Among 84,085
women and 43,371 men in the Harvard cohorts fol-
lowed for 28 and 22 years, respectively, $1 SSB
serving/day was associated with a 16% increased risk
of total stroke compared with no servings in
multivariable-adjusted models including BMI (20).
This association was attenuated and no longer sta-
tistically signiﬁcant after adjusting for hypertension
and diabetes, suggesting that these factors may be
mediators. In the multiethnic cohort of 2,564 resi-
dents in Northern Manhattan followed for a mean of
10 years, daily soft drink consumption was associated
with an increased risk of vascular events only in
participants free of obesity, diabetes, and metabolic
syndrome at baseline and adjusted for a number of
factors including BMI and hypertension (21). A Japa-
nese cohort of 39,786 men and women followed for
18 years found signiﬁcant positive associations be-
tween SSB intake and total and ischemic stroke in
women but not in men in models adjusted for hy-
pertension and diabetes (22). Adjustment for BMI and
total energy intake had little effect on estimates,
suggesting that these factors are not major mediators.
Intake of both added sugar and SSBs was associ-
ated with an increased risk for CVD mortality in an
analysis of NHANES III Linked Mortality cohort data
(4). After a median of 14.6 years of follow-up, added
sugar intake was associated with a 2-fold greater risk
of CVD death comparing extreme quintiles of intake.
In contrast, an analysis from the National Institutes of
Health–AARP Diet and Health Study, a prospective
cohort of older U.S. adults, found that intake of total
fructose but not of added sugar was associated with a
modest increase in risk of all-cause mortality in men
and women (23). However, total sugars from bever-
ages including added sugar were positively associ-
ated with risk of all-cause, CVD, and other-cause
mortality in women, whereas only fructose from
beverages was positively associated with risk of all-
cause and CVD mortality in men. The authors sug-
gest that the differential associations by sex may be
due to hormonal and biological differences or
different levels of dietary misreporting, but these
results may be also due to chance.
FRUCTOSE, GOUT, AND OTHER
METABOLIC CONDITIONS
Regular consumption of SSBs has been associated
with hyperuricemia as well as with gout, which is a
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1620common form of inﬂammatory arthritis arising from
deposition of uric acid in articular cartilage, in 2 large
cohorts (24,25). In particular, higher consumption of
both total and added fructose from SSBs was associ-
ated with increased risk of gout in a dose-response
manner. Gout and hyperuricemia have been associ-
ated with hypertension, diabetes, metabolic syn-
drome, kidney disease, and CVD (26). Consumption of
SSBs has also been associated with development of
albuminuria, a marker of early kidney damage; for-
mation of kidney stones; and increased risk of chronic
kidney disease (27,28). In the NHS II, sucrose con-
sumption was associated with an increased risk of
kidney stones (29). Observational studies have also
found that a higher intake of sucrose and fructose is
associated with a higher frequency of gallstones (30).
Individuals with either kidney disease or gallstones
have been shown to have elevated cardiovascular risk
(31,32). The studies discussed in this section reported
estimates that were adjusted for BMI, suggesting that
these associations are not completely dependent on
body weight.
RCTs OF FRUCTOSE, SSBs, AND
CARDIOVASCULAR RISK MARKERS
Data from short-term trials and experimental studies
of intermediate outcomes also provide important
evidence linking fructose-containing beverages with
diabetes and cardiovascular risk and support ﬁndings
from observational studies. Recently, Stanhope et al.
(11) showed that consuming beverages containing
10%, 17.5%, or 25% of energy requirements from HFCS
produced signiﬁcant linear dose-response increases
in post-prandial triglycerides, fasting low-density li-
poprotein (LDL) cholesterol, and 24-h mean uric acid
concentrations in a 2-week, parallel-arm, non-
randomized, double-blinded intervention study.
Raben et al. (33) found that a sucrose-rich diet
consumed for 10 weeks resulted in signiﬁcant eleva-
tions of post-prandial glycemia, insulinemia, and
lipidemia compared with a diet rich in artiﬁcial
sweeteners in overweight healthy subjects (33). A
randomized crossover trial among normal weight
healthy men found that after 3 weeks, SSBs consumed
in small to moderate quantities (600 ml SSB/day
containing 40 to 80 g of sugar) signiﬁcantly impaired
glucose and lipid metabolism and promoted inﬂam-
mation (34). Of note, LDL particle size was reduced
for high fructose and high sucrose SSBs. A 10-week
intervention comparing the effects of sucrose and
artiﬁcially sweetened food or beverages on markers of
inﬂammation found that serum levels of haptoglobin,
transferrin, and C-reactive protein were elevated inthe sucrose group compared with the sweetener
group (35).
BIOLOGICAL MECHANISMS:
LIQUID CALORIES AND UNIQUE
METABOLIC EFFECTS OF FRUCTOSE
The prevailing mechanisms linking SSB intake to
weight gain are decreased satiety and an incomplete
compensatory reduction in energy intake at subse-
quent meals following ingestion of liquid calories (6).
A typical 12 oz (360 ml) serving of soda contains on
average 140 to 150 calories and 35 to 37.5 g of sugar.
If these calories are added to the typical diet without
compensation for the additional calories, 1 can of
soda/day could, in theory, lead to a weight gain of
5 lbs in 1 year. Short-term feeding studies comparing
SSBs with artiﬁcially sweetened beverages in relation
to energy intake (36) and weight change (33,36–39)
illustrate this point. Some limited evidence support-
ing incomplete compensation for liquid calories has
also been provided by studies showing greater energy
intake after isocaloric consumption of beverages
compared with solid food (40,41). These studies argue
that sugar or HFCS in liquid beverages may not sup-
press intake of solid foods to the level needed to
maintain energy balance; however, the mechanisms
responsible for this response are largely unknown.
SSBs may contribute to the development of dia-
betes and cardiovascular risk in part through caloric
effects and the ability to induce weight gain, but
also independently through noncalorically-related
metabolic effects of constituent sugars (Central
Illustration). Consumption of SSBs has been shown
to induce rapid spikes in blood glucose and insulin
levels (33), which in combination with the large vol-
umes consumed, contribute to a high dietary glyce-
mic load (GL). High-GL diets are thought to stimulate
appetite and promote weight gain due to the higher
post-prandial insulin response following ingestion of
a high-GL meal (42) and have been shown to promote
hyperinsulinemia and insulin resistance (42). High-
GL diets have also been shown to exacerbate inﬂam-
matory biomarkers such as C-reactive protein (43) and
have been associatedwith an increased risk of diabetes
(44) and CHD (18,19). SSBs may affect risk of CHD
through effects on inﬂammation (45), which inﬂuences
atherosclerosis, plaque stability, and thrombosis (46).
Intake of SSBs could stimulate an inﬂammatory
response through hyperglycemia, which can activate
the electron transport chain to produce superoxide
radicals (47).
Some evidence suggests that consuming fructose
from SSBs as a constituent of sucrose, and HFCS in
CENTRAL ILLUSTRATION Fructose and Cardiometabolic Health: SSBs
Malik, V.S. et al. J Am Coll Cardiol. 2015; 66(14):1615–24.
Putative biological mechanisms linking excess sucrose and high fructose corn syrup intake from sugar-sweetened beverages (SSBs) to the development of
obesity, gout, diabetes, and cardiovascular disease. Excess calories, incomplete compensation for liquid calories, and high glycemic load (GL) lead to
obesity. Increased diabetes and cardiovascular disease risk also occur independently of weight through adverse glycemic effects and increased fructose
metabolism in the liver. Excess fructose ingestion promotes hepatic uric acid production, de novo lipogenesis, and accumulation of visceral adiposity and
ectopic fat, which ultimately increase diabetes and cardiovascular disease risk. ATP ¼ adenosine triphosphate.
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1621slightly higher amounts, and from fruit juices may
exert additional adverse cardiometabolic effects.
Fructose alone is poorly absorbed but is enhanced by
glucose in the gut, thus accounting for the rapid and
complete absorption of both fructose and glucose
when ingested as sucrose or HFCS. As previously
described, fructose is preferentially metabolized to
lipid in the liver and can lead to increased hepatic de
novo lipogenesis, atherogenic dyslipidemia, and insu-
lin resistance. The increase in hepatic lipid content
promotes production and secretionof very low-density
lipoprotein, leading to increased concentrations of
post-prandial triglyceride. Consumption of fructose-
containing sugars has been associated with produc-
tion of small dense LDL cholesterol, which may be due
to increased levels of very low-density lipoprotein–
induced lipoprotein remodeling, mediated by choles-
teryl ester transfer protein and hepatic lipase (9,11).
Fructose has also been shown to promote the
accumulation of visceral adipose tissue and thedeposition of ectopic fat (48,49). A 10-week study
comparing beverages providing 25% of energy from
fructose with a beverage providing 25% of energy
from glucose showed that fructose-containing bev-
erages increased de novo lipogenesis and visceral
adiposity, promoted dyslipidemia, and decreased in-
sulin sensitivity compared with the glucose beverage
(49). Another study compared daily intakes of 1 l/day
of cola, diet cola, milk, or water for 6 months and
found that intake of cola increased liver fat, visceral
fat, muscle fat, and triglycerides compared with the
other beverages (50). Fructose is also the only sugar
known to increase serum uric acid levels, which is
associated with the development of gout (51). Hepatic
uric acid production may also reduce endothelial
nitric oxide, which may partly explain the association
between SSB and CHD (52). Fructose has also
been shown to stimulate transcription of inﬂam-
matory factors by activating nuclear factor-kB
in mice, further supporting inﬂammation as a
TABLE 3 Policy Stra
Social marketing and p
effects of SSBs and
Governments should im
price increase, and
purchases of health
Regulations are needed
the media and at sp
Front of package label
guide consumers to
accompanied by co
Policies should be put
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and healthy alterna
Educational campaigns
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National and internatio
include the health r
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SNAP ¼ Supplemental Nut
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1622potential pathway between SSB and CHD (53). A
recent meta-analysis found that fructose in isocaloric
exchange with glucose increased total cholesterol,
uric acid, and post-prandial triglycerides but had no
adverse effect on other lipid parameters, insulin, or
markers of nonalcoholic fatty liver disease and may
be beneﬁcial for body weight, blood pressure, and
glycemic control (54). As discussed by the authors,
interpretation of these data was limited by the high
dose range studied, negative comparators (glucose
and starch), short follow-up, and methodological
limitations of the available trials (54).
HEALTHY-ALTERNATIVES TO SSBs AND
POLICY STRATEGIES
Several beverages have been suggested as alternatives
to SSBs, including water, 100% fruit juice, coffee, tea,
and artiﬁcially sweetened drinks. Unlike SSBs, water
does not contain liquid calories, and for most people
with access to safe drinking water, water is the optimal
calorie-free beverage because it is affordable and
accessible. We found that replacement of 1 serving/
day of SSBs with water was associated with 0.49 kg
less weight gain over each 4-year period (55). In the
NHS II, substituting water for SSBs was also associated
with a signiﬁcantly lower risk of diabetes (56).
Because juices contain some vitamins and other
nutrients, 100% fruit juice could be perceived as a
healthy alternative to SSBs. However, fruit juices
also contain a relatively high number of calories from
natural sugars, with likely greater amounts of fruc-
tose. Previous cohort studies have found positive
associations between consumption of fruit juice and
greater weight gain (57) and diabetes (58), althoughtegies to Reduce Consumption of SSBs
ublic health campaigns are needed to raise awareness about the health
added sugar and about healthy alternatives.
pose ﬁnancial disincentives, such as taxation of SSBs of at 1east a 10%
implement limits for use of SNAP beneﬁts for SSBs or subsidize SNAP
ier foods to encourage healthier beverage choices.
to reduce exposure to marketing of unhealthy foods and beverages in
orts events or other activities, particularly in relation to children.
ing or other nutrition labeling strategies should be implemented to help
make healthy food and beverage choices. These changes should be
ncurrent public health awareness campaigns.
in place to reduce the availability of SSBs in the workplace, health care
nt institutions, and other public places and ensure access to safe water
tives. Restrictions should also be put in place on large portion sizes.
about the health risks associated with overconsumption of SSBs should
care professionals and clinical populations.
nal campaigns targeting obesity and chronic disease prevention should
isks associated with overconsumption of SSBs.
nal dietary recommendations should include speciﬁc guidelines for
onsumption.
rition Assistance Program; SSB ¼ sugar-sweetened beverage.some conﬂicting evidence exists (57,59), suggesting
that further research exploring the health effects of
juice is warranted. Nonetheless, on the basis of cur-
rent evidence, it has been recommended that daily
intake of fruit juices be limited to 4 to 6 oz.
Numerous prospective cohort studies have shown
that regular consumption of coffee (decaffeinated or
regular) and tea can have favorable effects on diabetes
and CVD risk (60,61), possibly because of their high
polyphenol content. Thus, coffee and tea are healthy
alternatives to SSBs for individuals without contrain-
dications, provided that caloric sweeteners and
creamers are used sparingly. In the NHS II, substitut-
ing 1 serving of SSBs with 1 cup of coffee daily was
associated with a 17% lower risk of diabetes (62).
Artiﬁcially sweetened beverages may be a reason-
able alternative to SSBs because they provide few to
no calories; however, little is known about the long-
term health consequences of consuming artiﬁcial
sweeteners. Some studies have reported positive as-
sociations among diet soda consumption and weight
gain, risk of metabolic syndrome, and diabetes
(63,64). However, these ﬁndings may be due to
reverse causation or residual confounding, and short-
term trials have reported modest beneﬁts on weight
with artiﬁcially sweetened beverages as a replace-
ment for SSBs, but long-term data are lacking (7). Yet,
some evidence suggests that the intense sweetness of
artiﬁcial sweeteners may condition toward a greater
preference for sweets and enhanced appetite (6).
Although consumption of artiﬁcially sweetened bev-
erages is preferable to SSBs in the short term, further
studies are needed to evaluate their long-term
metabolic consequences.
In light of the evidence linking regular consump-
tion of SSBs to obesity and related chronic diseases,
national and international organizations have already
called for reductions in intake of these beverages to
help prevent obesity and improve overall health. The
American Heart Association recommends no more
than 100 to 150 kcal/day from all added sugar, and
both the World Health Organization and 2015 Dietary
Guidelines Advisory Committee recommend an upper
limit of 10% of total energy from added sugar.
Numerous other professional organizations also have
speciﬁc recommendations for limiting intake of SSBs.
In addition to strong and widespread public health
recommendations, public policy interventions are
needed to change consumption patterns, because
they can bring about rapid and effective changes in
the food environment. Proposed changes to the
nutrition facts label by the U.S. Food and Drug
Administration include listing the amounts of added
sugar in a product and the percent daily value (%DV)
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1623for added sugar. A combination of strategies across
multiple levels is thus needed to reduce intake of
SSBs, as illustrated in Table 3. Implementing and
evaluating these types of strategies on changes in
consumers’ purchasing and eating behaviors as well
as health outcomes should be a high priority.
CONCLUSIONS
Intake of added sugar, predominantly sucrose and
HFCS from SSBs, has increased markedly in the
United States since the late 1960s and constitutes the
major source of fructose in the U.S. diet. In this re-
gard, and because we rarely consume fructose in
isolation, it is logical to gauge the potential car-
diometabolic effects of fructose by evaluating asso-
ciations with SSBs. Although consumption of SSBs
has decreased moderately in recent years, intake
levels remain high in the U.S. population and are
increasing rapidly in developing countries. On the
basis of available evidence from high-quality obser-
vational studies and experimental trials of risk mar-
kers, we conclude that consumption of SSBs causes
excess weight gain and is associated with increased
risk of type 2 diabetes and CVD; thus, these beverages
are unique dietary contributors to obesity and related
chronic diseases. SSBs are thought to promote weight
gain in part due to excess calories and incomplete
compensation for liquid calories at subsequent meals.
These beverages may also increase diabetes and car-
diovascular risk independently through an adverse
glycemic response and unique metabolic effects of
fructose. Short-term mechanistic studies have shownthat excess fructose ingestion can result in additional
cardiometabolic effects due to increased hepatic de
novo lipogenesis, accumulation of visceral adiposity,
and ectopic fat and production of uric acid.
Several public policy and regulatory strategies to
reduce intake of SSBs are already in place or are being
considered. Implementing and evaluating such pol-
icies are important areas for scientists and policy-
makers. Key areas that warrant future research include
examining the effects of different sugars and sugar
moieties on health outcomes over a broad range of
doses, investigating the health effects of sugar con-
sumed in solid form in comparison to liquid sugar,
and further elucidating the biological mechanism by
which intake of liquid calories induces an incomplete
compensatory intake of energy at subsequent meals.
There is also a need for additional studies to examine
the long-term health effects of consuming artiﬁcial
sweeteners as a substitute for sugar. Lastly, more and
higher-quality RCTs are needed to identify effective
strategies to reduce SSB consumption at the individual
and population level. Although reducing consumption
of SSBs or added sugar alone is unlikely to solve the
obesity epidemic entirely, limiting intake is 1 simple
change that will have a measurable effect on weight
control and prevention of cardiometabolic diseases.
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